MedTrace Logo

BOSCOT : A Randomised Controlled Trial of Cognitive Behavioural Therapy in Borderline Personality Disorder

NCT00538135 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 106

Last updated 2007-10-02

No results posted yet for this study

Summary

The aim of the study was to investigate if the addition of cognitive behavioural therapy to treatment as usual (CBT plus TAU) in participants with borderline personality disorder would decrease the number of participants with emergency (i.e. unplanned) psychiatric or accident and emergency room contact or episode of deliberate self-harm over twelve months treatment and twelve months follow-up, compared with treatment as usual (TAU). The study also examined whether CBT plus TAU would lead to superior improvement in quality of life, social, cognitive and mental health functioning than TAU alone.

Conditions

  • Borderline Personality Disorder

Interventions

BEHAVIORAL

Cognitive Behavioural Therapy

OTHER

Treatment as usual

Standard National Health Service treatment as usual for borderline personality disorder

Sponsors & Collaborators

  • Wellcome Trust

    collaborator OTHER

  • University of Glasgow

    collaborator OTHER

  • University of London

    collaborator OTHER

  • University of York

    collaborator OTHER

  • University of Aberdeen

    lead OTHER

Principal Investigators

  • Kate Davidson, PhD · University of Glasgow

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-02-28
Completion
2005-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00538135 on ClinicalTrials.gov